Minoru Tanaka

5PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 05, 2026
Oncolytic Herpes Virus G47∆ Potentiates ADCC-Inducing Molecular Targeted Therapy via Coordinated Activation of Innate and Adaptive Immune Responses.

|Mar 19, 2025
Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.

Tomoki Todo, Hirotaka Ito, Yasushi Ino

|Jun 14, 2023
Increased PDGFRB and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms.

Yasuyuki Shima, Shota Sasagawa, Nakao Ota

|Jul 21, 2022
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.

Tomoki Todo, Hirotaka Ito, Yasushi Ino

|Jul 21, 2022
A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma.

Tomoki Todo, Yasushi Ino, Hiroshi Ohtsu

Pageof 1

Frequent Collaborators

4 joint publications

Tomoki Todo

3 joint publications

Yasushi Ino

3 joint publications

Hiroshi Ohtsu

1 joint publications

Yasuyuki Shima